CANDRIAM S.C.A. – Apellis Pharmaceuticals, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$23.46M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -44.19% | -271.95K shares | -4.36M | $68.3 | 343.50K |
| Q2 2022 | share | Increase | +32.05% | 149.36K shares | 4.14M | $45.22 | 615.45K |
| Q1 2022 | share | Decrease | -32.88% | -228.33K shares | -9.15M | $50.81 | 466.09K |
| Q4 2021 | share | Increase | +172.29% | 439.39K shares | 24.42M | $47.95 | 694.42K |
| Q3 2021 | share | Decrease | -19.63% | -62.28K shares | -11.64M | $32.96 | 255.03K |
| Q2 2021 | share | Decrease | -42.86% | -238.05K shares | -10.46M | $63.2 | 317.31K |
| Q1 2021 | share | 0.00% | 0 shares | -1.25M | $42.91 | 555.37K | |
| Q4 2020 | share | Decrease | -51.66% | -593.49K shares | -2.89M | $57.2 | 555.37K |
| Q3 2020 | share | Decrease | -5.08% | -61.53K shares | -4.87M | $30.17 | 1.14M |
| Q2 2020 | share | Increase | +208.62% | 818.19K shares | 27.79M | $32.66 | 1.21M |
| Q1 2020 | share | 0.00% | 0 shares | -269K | $26.79 | 392.2K | |
| Q4 2019 | share | Decrease | -9.78% | -42.5K shares | 1.53M | $30.62 | 392.2K |
| Q3 2019 | share | Decrease | -17.62% | -93K shares | -2.84M | $24.09 | 434.7K |
| Q2 2019 | share | 0.00% | 0 shares | 3.02M | $25.34 | 527.7K | |
| Q1 2019 | share | 0.00% | 0 shares | 3.33M | $19.5 | 527.7K | |
| Q4 2018 | share | Increase | +2.33% | 12K shares | -2.20M | $13.19 | 527.7K |
| Q3 2018 | share | Increase | +114.88% | 275.7K shares | 3.88M | $17.78 | 515.7K |
| Q2 2018 | share | Increase | +93.55% | 116K shares | 2.53M | $22 | 240K |
| Q1 2018 | share | Increase | +5.98% | 7K shares | 203K | $22.11 | 124K |
| Q4 2017 | share | Increase | 0.00% | 117K shares | 2.53M | $21.7 | 117K |